Pharming Group N.V.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $183.4M | $205.2M |
| FY2021 | — | $192.9M | $191.9M |
| FY2022 | — | $204.6M | $207.3M |
| FY2023 | — | $218.8M | $61.7M |
| FY2024 | — | $221.1M | $54.9M |
| FY2025 | — | $277.1M | $145.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $183.4M | $205.2M |
| FY2021 | — | $192.9M | $191.9M |
| FY2022 | — | $204.6M | $207.3M |
| FY2023 | — | $218.8M | $61.7M |
| FY2024 | — | $221.1M | $54.9M |
| FY2025 | — | $277.1M | $145.3M |